Neuman I, Elian R, Nahum H, Shaked P, Creter D
Clin Allergy. 1978 Jan;8(1):65-8. doi: 10.1111/j.1365-2222.1978.tb00449.x.
Oral administration of 50 mg tartrazine to 122 patients with a variety of allergic disorders caused the following reactions: general weakness, heatwaves, palpitations, blurred vision, rhinorrhoea, feeling of suffocation, pruritus and urticaria. There was activation of the fibrinolytic pathway as shown by reduction of plasminogen with high pre-kallikrein and low kallikrein values. Reduction in complement activity (CH50) was seen in three out of sixteen reactions.